Logo image of CHR-DB-B.CA

CHORUS AVIATION INC (CHR-DB-B.CA) Stock Fundamental Analysis

TSX:CHR-DB-B - Toronto Stock Exchange - CA17040TAE25 - Currency: CAD

100.5  +0.24 (+0.24%)

Fundamental Rating

4

CHR-DB-B gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 9 industry peers in the Passenger Airlines industry. Both the profitability and the financial health of CHR-DB-B get a neutral evaluation. Nothing too spectacular is happening here. CHR-DB-B is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year CHR-DB-B was profitable.
In the past year CHR-DB-B had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CHR-DB-B reported negative net income in multiple years.
Each year in the past 5 years CHR-DB-B had a positive operating cash flow.
CHR-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

CHR-DB-B has a worse Return On Assets (-17.42%) than 77.78% of its industry peers.
The Return On Equity of CHR-DB-B (-47.80%) is worse than 66.67% of its industry peers.
The Return On Invested Capital of CHR-DB-B (6.29%) is better than 77.78% of its industry peers.
CHR-DB-B had an Average Return On Invested Capital over the past 3 years of 5.30%. This is in line with the industry average of 5.50%.
The 3 year average ROIC (5.30%) for CHR-DB-B is below the current ROIC(6.29%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -17.42%
ROE -47.8%
ROIC 6.29%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR-DB-B.CA Yearly ROA, ROE, ROICCHR-DB-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

Looking at the Operating Margin, with a value of 6.77%, CHR-DB-B is in line with its industry, outperforming 44.44% of the companies in the same industry.
In the last couple of years the Operating Margin of CHR-DB-B has declined.
CHR-DB-B has a Gross Margin of 65.04%. This is in the better half of the industry: CHR-DB-B outperforms 77.78% of its industry peers.
CHR-DB-B's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.77%
PM (TTM) N/A
GM 65.04%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR-DB-B.CA Yearly Profit, Operating, Gross MarginsCHR-DB-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CHR-DB-B is destroying value.
Compared to 1 year ago, CHR-DB-B has less shares outstanding
Compared to 5 years ago, CHR-DB-B has more shares outstanding
Compared to 1 year ago, CHR-DB-B has an improved debt to assets ratio.
CHR-DB-B.CA Yearly Shares OutstandingCHR-DB-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHR-DB-B.CA Yearly Total Debt VS Total AssetsCHR-DB-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 2.24 indicates that CHR-DB-B is not a great score, but indicates only limited risk for bankruptcy at the moment.
CHR-DB-B has a Altman-Z score of 2.24. This is amongst the best in the industry. CHR-DB-B outperforms 88.89% of its industry peers.
CHR-DB-B has a debt to FCF ratio of 3.86. This is a good value and a sign of high solvency as CHR-DB-B would need 3.86 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 3.86, CHR-DB-B is doing good in the industry, outperforming 77.78% of the companies in the same industry.
CHR-DB-B has a Debt/Equity ratio of 0.68. This is a neutral value indicating CHR-DB-B is somewhat dependend on debt financing.
CHR-DB-B's Debt to Equity ratio of 0.68 is fine compared to the rest of the industry. CHR-DB-B outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 3.86
Altman-Z 2.24
ROIC/WACC0.72
WACC8.79%
CHR-DB-B.CA Yearly LT Debt VS Equity VS FCFCHR-DB-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.22 indicates that CHR-DB-B should not have too much problems paying its short term obligations.
CHR-DB-B's Current ratio of 1.22 is in line compared to the rest of the industry. CHR-DB-B outperforms 44.44% of its industry peers.
A Quick Ratio of 0.71 indicates that CHR-DB-B may have some problems paying its short term obligations.
The Quick ratio of CHR-DB-B (0.71) is worse than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.71
CHR-DB-B.CA Yearly Current Assets VS Current LiabilitesCHR-DB-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

CHR-DB-B shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.14%.
The earnings per share for CHR-DB-B have been decreasing by -19.03% on average. This is quite bad
CHR-DB-B shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.15%.
CHR-DB-B shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.56% yearly.
EPS 1Y (TTM)-5.14%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%35.71%
Revenue 1Y (TTM)-14.15%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-18.31%

3.2 Future

The Earnings Per Share is expected to grow by 8.82% on average over the next years. This is quite good.
Based on estimates for the next years, CHR-DB-B will show a small growth in Revenue. The Revenue will grow by 0.78% on average per year.
EPS Next Y62.27%
EPS Next 2Y16.29%
EPS Next 3Y8.82%
EPS Next 5YN/A
Revenue Next Year-2.29%
Revenue Next 2Y-2.03%
Revenue Next 3Y0.78%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CHR-DB-B.CA Yearly Revenue VS EstimatesCHR-DB-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CHR-DB-B.CA Yearly EPS VS EstimatesCHR-DB-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 60.54, CHR-DB-B can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of CHR-DB-B is on the same level as its industry peers.
When comparing the Price/Earnings ratio of CHR-DB-B to the average of the S&P500 Index (27.41), we can say CHR-DB-B is valued expensively.
With a Price/Forward Earnings ratio of 49.22, CHR-DB-B can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as CHR-DB-B.
CHR-DB-B's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 35.19.
Industry RankSector Rank
PE 60.54
Fwd PE 49.22
CHR-DB-B.CA Price Earnings VS Forward Price EarningsCHR-DB-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHR-DB-B is valued a bit more expensive than the industry average as 77.78% of the companies are valued more cheaply.
CHR-DB-B's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 24.51
EV/EBITDA 16.36
CHR-DB-B.CA Per share dataCHR-DB-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.97
PEG (5Y)N/A
EPS Next 2Y16.29%
EPS Next 3Y8.82%

More info and screens

0

5. Dividend

5.1 Amount

CHR-DB-B does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHORUS AVIATION INC

TSX:CHR-DB-B (7/10/2025, 7:00:00 PM)

100.5

+0.24 (+0.24%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners2.5%
Inst Owner ChangeN/A
Ins Owners1.32%
Ins Owner ChangeN/A
Market Cap2.66B
Analysts78.18
Price Target133.9 (33.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-7.29%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.69%
Min EPS beat(2)3.87%
Max EPS beat(2)25.51%
EPS beat(4)3
Avg EPS beat(4)39.29%
Min EPS beat(4)-80.2%
Max EPS beat(4)207.96%
EPS beat(8)4
Avg EPS beat(8)7.83%
EPS beat(12)5
Avg EPS beat(12)1.78%
EPS beat(16)7
Avg EPS beat(16)0.15%
Revenue beat(2)0
Avg Revenue beat(2)-3.86%
Min Revenue beat(2)-3.95%
Max Revenue beat(2)-3.78%
Revenue beat(4)0
Avg Revenue beat(4)-6.49%
Min Revenue beat(4)-10.27%
Max Revenue beat(4)-3.78%
Revenue beat(8)3
Avg Revenue beat(8)-1.85%
Revenue beat(12)5
Avg Revenue beat(12)-1.08%
Revenue beat(16)9
Avg Revenue beat(16)6.44%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.14%
EPS NY rev (1m)0%
EPS NY rev (3m)8.79%
Revenue NQ rev (1m)-0.29%
Revenue NQ rev (3m)-0.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 60.54
Fwd PE 49.22
P/S 1.91
P/FCF 24.51
P/OCF 17.8
P/B 5.15
P/tB 5.24
EV/EBITDA 16.36
EPS(TTM)1.66
EY1.65%
EPS(NY)2.04
Fwd EY2.03%
FCF(TTM)4.1
FCFY4.08%
OCF(TTM)5.65
OCFY5.62%
SpS52.7
BVpS19.51
TBVpS19.18
PEG (NY)0.97
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.42%
ROE -47.8%
ROCE 8.48%
ROIC 6.29%
ROICexc 6.74%
ROICexgc 6.8%
OM 6.77%
PM (TTM) N/A
GM 65.04%
FCFM 7.78%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexcg growth 3Y33.52%
ROICexcg growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 3.86
Debt/EBITDA 1.9
Cap/Depr 45.9%
Cap/Sales 2.93%
Interest Coverage 1.46
Cash Conversion 81.41%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.71
Altman-Z 2.24
F-Score6
WACC8.79%
ROIC/WACC0.72
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.14%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%35.71%
EPS Next Y62.27%
EPS Next 2Y16.29%
EPS Next 3Y8.82%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.15%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-18.31%
Revenue Next Year-2.29%
Revenue Next 2Y-2.03%
Revenue Next 3Y0.78%
Revenue Next 5YN/A
EBIT growth 1Y-59.15%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year88.24%
EBIT Next 3Y15.21%
EBIT Next 5YN/A
FCF growth 1Y-55.84%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-51.04%
OCF growth 3Y12.73%
OCF growth 5Y0.25%